跳至主要内容
临床试验/NCT05074758
NCT05074758已完成不适用

Characterization of the microVAScular Dysfunction in COvid-19 ARDS

Assistance Publique - Hôpitaux de Paris2 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2021年12月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
39
试验地点
2
主要终点
Prognostic value of alveolar dead space

研究概览

简要总结

The primary endpoint of this research is to establish that the alveolar dead space is significantly higher in patients with COVID-19 ARDS, compared to patients with non-COVID-19 ARDS.

Secondarily, the investigators want to establish the prognostic value of the alveolar-dead space (measured iteratively) in patients with COVID-19 and non-COVID-19 ARDS, to establish the respective influences of the biological parameters of endothelial damage, of the biological parameters of coagulopathy, of the parameters set on the artificial ventilator on the value of the alveolar dead space; in ARDS patients with COVID-19 and non-COVID-19 ARDS, to establish the prognostic value of the laboratory parameters of endothelial damage and coagulopathy in patients with COVID-19 and non-COVID-19 ARDS.

详细描述

Endothelial damage and coagulation activation at the lung microvascular level may play an important role in the physiopathology of the COVID-19 ARDS. The project aims to prospectively investigate both bedside pulmonary physiological markers and biological markers of coagulopathy and endothelial dysfunction in COVID-19 and non-COVID-19 ARDS patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age> 18 years old
  • Invasive mechanical ventilation in place for less than 48 hours
  • Severe or moderate ARDS (defined according to the Berlin classification)
  • Virological confirmation by PCR of SARS-CoV-2 infection (ARDS COVID-19)
  • Lack of virological confirmation by PCR of SARS-CoV-2 infection (ARDS not linked to COVID-19)
  • Patient information

排除标准

  • Massive pulmonary embolism
  • Chronic respiratory failure under long-term oxygen therapy
  • Dying patient

结局指标

主要结局

Prognostic value of alveolar dead space

时间窗: Up to 28 days

Recording the exhaled CO2 curve (side-stream capnography method) and volume curve, as determined by the mechanical ventilator, and computing the signals with the arterial CO2 partial pressure, reflecting the partial pressure of CO2 in the alveoli participating in gas exchanges), determined on arterial blood gas (ABG) sampling.

次要结局

  • Level of circulating endothelial cells(Up to 28 days)
  • Prognostic value of the alveolar dead space (measured iteratively)(28 days)
  • Level of endothelial proteomics(Up to 28 days)
  • Level of Willebrand Factor(Up to 28 days)
  • Level of fragments of plasminogen(Up to 28 days)
  • Level of the components of the NETs (Neutrophil Extracellular Traps)(Up to 28 days)
  • Level of progenitor cells(Up to 28 days)
  • Level of circulating stem cells(Up to 28 days)
  • Level of D-dimers(Up to 28 days)
  • Level of components of the fibrinolytic system(Up to 28 days)
  • Survival rate(90 days)
  • Prognostic value of the alveolar dead space (measured iteratively)(20 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验